Luenemann JD, Waiczies S, Ehrlich S, Wendling U, Seeger B, Kamradt T, Zipp F. Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells. J Immunol. 2002 May 15: 168(10):4881-8.

Wandinger KP, Lunemann JD, Wengert O, Bellmann-Strobl J, Aktas O, Weber A, Grundstrom E, Ehrlich S, Wernecke KD, Volk HD, Zipp F. TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis. Lancet. 2003 Jun 14;361(9374):2036-43.

Ehrlich S, Infante-Duarte C, Seeger B, Zipp F. Regulation of soluble and surface-bound TRAIL in human T cells, B cells, and monocytes. Cytokine. 2003 Dec 21;24(6):244-53.

Weber A, Wandinger KP, Mueller W, Aktas O, Wengert O, Ehrlich S, Windemuth C, Kuhlmann T, Wienker T, Bruck W, Zipp F. Identification and functional characterization of a highly polymorphic region in the human TRAIL promoter in multiple sclerosis. J Neuroimmunol. 2004 Apr;149(1-2):195-201.

Ehrlich S, Noam GG, Lyoo IK, Kwon BJ, Clark MA, Renshaw PF.Subanalysis of the location of white matter hyperintensities and their association with suicidality in children and youth. Ann N Y Acad Sci. 2003 Dec;1008:265-8.

Ehrlich S, Noam GG, Lyoo IK, Kwon BJ, Clark MA, Renshaw PF.White Matter Hyperintensities and their Associations with Suicidality in psychiatrically hospitalized Children and Adolescents. J Am Acad Child Adolesc Psychiatry. 2004 Jun;43(6):770-6

Ehrlich S, Breeze JL, Heesdorffer DC, Noam GG, Gong X, Alban RL, Davis SE, Renshaw PF. White Matter Hyperintensities and their Associations with Suicidality in psychiatrically hospitalized Young Adults. J Affect Disord. 2005 Jun;86(2-3):281-7.

Ehrlich S, Infante-Duarte C, Haas J, Zipp F. No relationship between serum CD95 levels and the suppression of MS during pregnancy. (Manuskript in Revision)